We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Bayer and Evotec partner Haplogen will work to identify new treatments for pulmonary diseases including chronic obstructive pulmonary disease (COPD) under a multiyear drug discovery and development collaboration.